Differential effects of escitalopram on attention: A placebo-controlled, double-blind cross-over study

Psychopharmacology

Volumn 207, Issue 2, 2009, Pages 213-223

  Drueke, Barbara ^a   Baetz, Julia ^a   Boecker, Maren ^a   Moeller, Olaf ^a   Hiemke, Christoph ^b   Gründer, Gerd ^a   Gauggel, Siegfried ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

5 HT; Attention; Attention Network Test (ANT); Escitalopram; Humans

Indexed keywords

ESCITALOPRAM; PLACEBO;

ADULT; APPETITE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; HUMAN; LIBIDO; MAJOR DEPRESSION; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; REPEATED DRUG DOSE; SIDE EFFECT; SINGLE DRUG DOSE; SLEEP DISORDER; TABLET; TREATMENT RESPONSE; VERTIGO;

ADOLESCENT; ADULT; ATTENTION; CITALOPRAM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; REACTION TIME; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 70449376992     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1649-6     Document Type: Article

References (48)

1. JK Abrams PL Johnson A Hay-Schmidt JD Mikkelsen A Shekhar CA Lowry 2005 Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs Neuroscience 133 4 983 97 10.1016/j.neuroscience.2005.03.025 1:CAS:528:DC%2BD2MXlt1KhsLc%3D 15916857 (Pubitemid 40814606)
2. S Aronson P Delgado 2004 Escitalopram Drugs Today 40 2 121 131 10.1358/dot.2004.40.2.799424 1:CAS:528:DC%2BD2cXjtlahtro%3D 15045034 (Pubitemid 38387617)
3. C Balducci M Nurra A Pietropoli R Samanin M Carli 2003 Revearsal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by cholinesterase inhibitor donezepil and by a 5-HT1A receptor antagonist WAY 100635 Psychopharmacology 167 28 36 1:CAS:528: DC%2BD3sXislyqsLY%3D 12618916
4. SJ Ballaz H Akil SJ Watson 2007 The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behaviour Neuroscience 149 1 192 202 10.1016/j.neuroscience.2007.07.043 1:CAS:528:DC%2BD2sXhtFemtb%2FE 17869441 (Pubitemid 47488662)
5. WJ Burke 2002 Escitalopram Expert Opin Investig Drugs 11 10 1477 1486 10.1517/13543784.11.10.1477 1:CAS:528:DC%2BD38XnvFOhtro%3D 12387707 (Pubitemid 35174942)
6. WJ Burke I Gergel A Bose 2002 Fixed-dose trial of the single isomer SSRI escitalopram in depressed patients J Clin Psychiatry 63 331 336 1:CAS:528:DC%2BD38XjslCktL0%3D 12000207
7. 2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five choice serial reaction time task Psychopharmacology 106 228 234 10.1007/BF02801977 1:CAS:528:DyaK38Xhs1Kitbg%3D 1532259
8. M Carli R Samanin 2000 The 5-HT1A receptor agonist 8-OH-PHAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT1A receptors Psychopharmacology 149 259 268 10.1007/s002139900368 1:CAS:528: DC%2BD3cXjs1GhsbY%3D 10823407 (Pubitemid 30262340)
9. HF Clarke SC Walker HS Crofts JW Dalley TW Robbins AC Roberts 2005 Prefrontal serotonin depletion affects revearsal learning but not attentional set shifting J Neurosci 25 532 538 10.1523/JNEUROSCI.3690-04.2005 1:CAS:528:DC%2BD2MXptV2hsQ%3D%3D 15647499 (Pubitemid 40105626)
10. HF Clarke SC Walker JW Dallex TW Robbins AC Roberts 2007 Cognitive inflexibility after prefrontal serotonin depletion is behaviourally and neurochemically specific Cereb Cortex 17 1 18 27 10.1093/cercor/bhj120 1:STN:280:DC%2BD28jhvFaltw%3D%3D 16481566 (Pubitemid 44973891)
11. Cohen J (1988) Statistical power analysis for the behavioural sciences, 2nd edn. Lawrence Earlbaum Associates, Hillsdale
12. BA Eriksen CW Ericksen 1974 Effects of noise letters upon the identification of a target letter in a nonsearch task Percept Psychophys 16 143 149
13. J Fan BD McCandliss T Sommer A Raz MI Posner 2002 Testing the efficiency and independence of attentional networks J Cogn Neurosci 14 3 340 347 10.1162/089892902317361886 11970796 (Pubitemid 34267537)
14. J Fan BD McCandliss J Fossella JI Flombaum MI Posner 2005 The activation of attentional networks Neuroimage 26 2 471 479 10.1016/j.neuroimage.2005.02.004 15907304 (Pubitemid 40719825)
15. F Faul E Erdfelder AG Lang A Buchner 2007 G*Power3: a flexible statistical power analysis program for the social, behavioural, and biomedical sciences Behav Res Meth 39 175 191
16. D Fernandez-Duque MI Posner 1997 Relating the mechanisms of orienting and alerting Neuropsychologia 35 4 477 486 10.1016/S0028-3932(96)00103-0 1:STN:280:DyaK2s3mtVWrsw%3D%3D 9106276 (Pubitemid 27144000)
17. D Fernandez-Duque MI Posner 2001 Brain imaging of attentional networks in normal and pathological states J Clin Exp Neuropsychol 23 74 93 10.1076/jcen.23.1.74.1217 1:STN:280:DC%2BD3M3is1Cnsw%3D%3D 11320446 (Pubitemid 32204873)
18. Gray JA (1982) The neuropsychology of anxiety: an inquiry into the functions of the septo-hippcampal system. Clarendon Press, Oxford
19. Gray JA, Smith T (1969) An arousal-decision model for partial reinforcement and discrimination learning. In: Gilbert R, Sutherland N (eds) Animal Discrimination Learning. Academic Press, New York, pp 243-272
20. Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic Press, Orlando
21. J Hennig S Huwe P Netter 1997 The antagonism of ipsapirone induced biobehavioral responses by ±pindolol in high and low impulsives J Neural Transm 104 1027 1035 10.1007/BF01273316 1:CAS:528:DyaK1cXhsVCksbo%3D 9503255 (Pubitemid 28031669)
22. J Hennig A Kroeger B Meyer H Prochaska P Krien S HUwe P Netter 1998 Personality correlates of ±pindolol induced decreases in prolactin Pharmacopsychiatry 31 19 24 10.1055/s-2007-979290 1:CAS:528:DyaK1cXitlGjsbc%3D 9524980
23. 123I]ADAM in healthy subjects administered different doses of escitalopram or Citalopram Psychpharmacology 188 263 272 10.1007/s00213-006- 0486-0 1:CAS:528:DC%2BD28XpsFWmtLk%3D (Pubitemid 44387454)
24. 123I]ADAM SPECT study Psychopharmacology 191 333 339 10.1007/s00213-006-0666-y 1:CAS:528: DC%2BD2sXitlCksbo%3D 17235610 (Pubitemid 46354624)
25. T Koskinen S Ruotsalainen T Puumala R Lappalainen E Koivisto PT Mannisto J Sirvio 2000 Activation of 5-HT2A receptors impairs response control in rats in a five-choice serial reaction time task Neuropharmacology 39 471 481 10.1016/S0028-3908(99)00159-8 1:CAS:528:DC%2BD3cXmtVGhtQ%3D%3D 10698013 (Pubitemid 30052936)
26. M Lader A Melhuish G Fricka K Fredericson Overo V Christensen 1986 The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy subjects Eur J Clin Pharmacol 31 183 190 10.1007/BF00606656 1:CAS:528:DyaL2sXktl2jtg%3D%3D 3467975 (Pubitemid 17014587)
27. HY Meltzer 1999 The role serotonin in antipsychotic drug action Neuropsychopharmacology 21 106S 115S 1:CAS:528:DyaK1MXltVOntb8%3D 10432496
28. HY Meltzer Z LI Y Kaneda J Ichikawa 2003 Serotonin receptors: their key role in drugs to treat schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 27 7 1159 72 10.1016/j.pnpbp.2003.09.010 1:CAS:528:DC%2BD3sXpt1SgtLg%3D 14642974 (Pubitemid 37464960)
29. C Mirjana M Baviera RW Invernizzi C Balducci 2004 The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex Neuropsychopharmacology 29 1637 1647 10.1038/sj.npp.1300479 1:CAS:528:DC%2BD2cXmvVOqsb8%3D 15127084 (Pubitemid 39150105)
30. R Mongeau P Blier C de Montigy 1997 The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments Brains Res Rev 23 3 145 195 10.1016/S0165-0173(96)00017-3 1:CAS:528:DyaK2sXisFKgu7s%3D (Pubitemid 27189731)
31. PJ Nathan G Sitaram C Stough RB Silberstein A Sali 2000 Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor Behav Pharmacol 11 639 642 1:CAS:528:DC%2BD3MXitFSitg%3D%3D 11198135
32. P Netter J Hennig S Rohrmann 1999 Psychobiological differences between aggression and psychoticism Pharmacopsychiatry 32 5 12 10.1055/s-2007-979182 1:STN:280:DyaK1M7mvVOgtw%3D%3D 10071177
33. SO Ogren TM Eriksson E Elvander-Tottie C D'Addario JC Ekstroem P Svenningsson B Meister J Kehr O Stiedl 2008 The role of 5-HT(1A) receptors in learning and memory Behav Brain Res 10.1016/j.bbr.2008.02.023 18394726
34. T Rammsayer P Netter 1988 Effects of changes in brain 5-HT activity on indicators for cortical arousal Int Clin Psychopharmacol 3 231 237 10.1097/00004850-198807000-00004 1:STN:280:DyaK3M%2FnvFCmtw%3D%3D 3155282
35. WJ Riedel T Klaassen NEP Deutz A van Someren HM van Praag 1999 Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation Psychopharmacology 141 362 369 10.1007/s002130050845 1:CAS:528:DyaK1MXhtlyju7k%3D 10090643 (Pubitemid 29190004)
36. WJ Riedel K Eikmans A Heldens JAJ Schmitt 2005 Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment J Psychopharmacol 19 1 12 20 10.1177/0269881105048887 1:CAS:528:DC%2BD2MXhs1Onur0%3D 15671124
37. M Reis CB Chermá F Bengtsson 2007 Therapeutic drug monitoring of escitalopram in an outpatient setting Ther Drug Monit 29 6 758 766 10.1097/FTD.0b013e31815b3f62 1:CAS:528:DC%2BD2sXhtlGhsr7M 18043473 (Pubitemid 350190852)
38. TW Robbins 1997 Arousal systems and attentional processes Biol Psychol 45 57 71 10.1016/S0301-0511(96)05222-2 1:STN:280:DyaK2s3jslWltA%3D%3D 9083644 (Pubitemid 27110537)
39. TW Robbins 2007 Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications Philos Trans R Soc Lond B Biol Sci 362 917 932 10.1098/rstb.2007.2097 1:STN:280:DC%2BD2s3hs1yhtg%3D%3D 17412678 (Pubitemid 47056819)
40. TW Robbins AC Roberts 2007 Differential regulation of fronto-executive function by the monoamines and acetylcholine Cereb Cortex 17 i151 i160 10.1093/cercor/bhm066 17725997
41. SJAJ Riedel VEFPM WJ M Kruizinga JG Ramaekers 2002 Modulation of the critical flicker fusion effects of serotonin reuptake inhibitors by concomitant papillary changes Psychopharmacology 160 381 386 10.1007/s00213-001-0993-y 11919665 (Pubitemid 34253280)
42. B Sogaard H Mengel N Rao F Larsen 2005 The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects J Clin Pharmacol 45 12 1400 1406 10.1177/ 0091270005280860 1:CAS:528:DC%2BD2MXhtlSjtr3E 16291715 (Pubitemid 41642443)
43. Stahl SM (2005) Essential psychopharmacology. The prescriber's guide. University Press, Cambrigde
44. MMM Verheij KTG VeenflietJV M Steenhof AR Cools 2009 Individual differences in the sensitivity to serotonergic drugs: a pharmacobehavioural approach using rats selected on the basis of their response to novelty Psychopharmacology (Berl) 10.1007/s00213-009-1552-1
45. J Waugh KL Goa 2003 Escitalopram: a review of its use in the management of major depressive and anxiety disorders CNS Drugs 17 5 343 362 10.2165/00023210-200317050-00004 1:CAS:528:DC%2BD2MXoslGjurY%3D 12665392 (Pubitemid 36469972)
46. M Wingen KP Kuypers JG Ramaekers 2007 The role of 5-HT1A and 5-HT2A receptors in attention and motor control: a mechanistic study in healthy volunteers Psychpharmacology 190 3 391 400 10.1007/s00213-006-0614-x 1:CAS:528:DC%2BD2sXosFGqtg%3D%3D (Pubitemid 46155648)
47. F Yasuno T Suhara T Nakayama T Ichimiya Y Okubo A Takano T Anso M Inoue J Maeda K Suzuki 2004 Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory Am J Psychiatry 161 8 1505 1506 10.1176/appi.ajp.161.8.1505-a
48. VY Yevtushenko AI Belous YG Yevtushenko SE Gsinin OJ Buzik TV Agibalova 2007 Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients Clin Ther 29 11 2319 2332 10.1016/j.clinthera.2007.11.014 1:CAS:528:DC%2BD1cXhtVKjtL0%3D 18158074 (Pubitemid 350302036)